Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antiplatelet effects of a novel antianginal agent, nicorandil.
Jaraki O, Strauss WE, Francis S, Loscalzo J, Stamler JS. Jaraki O, et al. Among authors: strauss we. J Cardiovasc Pharmacol. 1994 Jan;23(1):24-30. doi: 10.1097/00005344-199401000-00024. J Cardiovasc Pharmacol. 1994. PMID: 7511731
Randomized trial of intravenous iron-induced hypophosphatemia.
Wolf M, Chertow GM, Macdougall IC, Kaper R, Krop J, Strauss W. Wolf M, et al. JCI Insight. 2018 Dec 6;3(23):e124486. doi: 10.1172/jci.insight.124486. JCI Insight. 2018. PMID: 30518682 Free PMC article. Clinical Trial.
Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study.
Vadhan-Raj S, Ford DC, Dahl NV, Bernard K, Li Z, Allen LF, Strauss WE. Vadhan-Raj S, et al. Among authors: strauss we. Am J Hematol. 2016 Feb;91(2):E3-5. doi: 10.1002/ajh.24240. Am J Hematol. 2016. PMID: 26572233 Free PMC article. Clinical Trial. No abstract available.
Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions.
Adkinson NF, Strauss WE, Bernard K, Kaper RF, Macdougall IC, Krop JS. Adkinson NF, et al. Among authors: strauss we. J Blood Med. 2017 Sep 26;8:155-163. doi: 10.2147/JBM.S142236. eCollection 2017. J Blood Med. 2017. PMID: 29033620 Free PMC article.
49 results